Retracted: Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cellsin vitro
International Journal of Cancer (2005) - Comments
pubmed: 15700310  doi: 10.1002/ijc.20917  issn: 0020-7136  issn: 1097-0215 

Claudio Festuccia, Giovanni Luca Gravina, Adriano Angelucci, Danilo Millimaggi, Paola Muzi, Carlo Vicentini, Mauro Bologna